| Product Code: ETC13307051 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Cell Gene Therapy CDMO Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Cell Gene Therapy CDMO Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Cell Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 North America Cell Gene Therapy CDMO Market - Industry Life Cycle |
3.4 North America Cell Gene Therapy CDMO Market - Porter's Five Forces |
3.5 North America Cell Gene Therapy CDMO Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Cell Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 North America Cell Gene Therapy CDMO Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.8 North America Cell Gene Therapy CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 North America Cell Gene Therapy CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 North America Cell Gene Therapy CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Cell Gene Therapy CDMO Market Trends |
6 North America Cell Gene Therapy CDMO Market, 2021 - 2031 |
6.1 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Viral Vector Manufacturing, 2021 - 2031 |
6.1.3 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Plasmid DNA Manufacturing, 2021 - 2031 |
6.1.4 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Cell Therapy Manufacturing, 2021 - 2031 |
6.1.5 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Cryopreservation Services, 2020 - 2028 |
6.2 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Lentiviral Vector Technology, 2021 - 2031 |
6.2.3 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Plasmid-Based Gene Delivery, 2021 - 2031 |
6.2.4 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By CAR-T Cell Expansion Technology, 2021 - 2031 |
6.2.5 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Controlled-Rate Freezing, 2021 - 2031 |
6.3 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Biopharmaceutical Companies, 2021 - 2031 |
6.3.3 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.3.4 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Hospitals and Clinics, 2021 - 2031 |
6.3.5 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Cell and Gene Therapy Developers, 2021 - 2031 |
6.4 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.2 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Gene Delivery for Cell Therapy, 2021 - 2031 |
6.4.3 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Preclinical and Clinical Studies, 2021 - 2031 |
6.4.4 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Oncology and Rare Diseases Treatment, 2020 - 2028 |
6.4.5 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Transport of Cell Therapies, 2020 - 2028 |
7 North America Cell Gene Therapy CDMO Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.1 United States (US) Cell Gene Therapy CDMO Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.2 Canada Cell Gene Therapy CDMO Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.3 Rest of North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3 North America Cell Gene Therapy CDMO Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
7.3.1 United States (US) Cell Gene Therapy CDMO Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3.2 Canada Cell Gene Therapy CDMO Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.3.3 Rest of North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.4 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Cell Gene Therapy CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Cell Gene Therapy CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Cell Gene Therapy CDMO Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.1 United States (US) Cell Gene Therapy CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.2 Canada Cell Gene Therapy CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.3 Rest of North America Cell Gene Therapy CDMO Market, Revenues & Volume, By Application, 2021 - 2031 |
8 North America Cell Gene Therapy CDMO Market Key Performance Indicators |
9 North America Cell Gene Therapy CDMO Market - Export/Import By Countries Assessment |
10 North America Cell Gene Therapy CDMO Market - Opportunity Assessment |
10.1 North America Cell Gene Therapy CDMO Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Cell Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.3 North America Cell Gene Therapy CDMO Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
10.4 North America Cell Gene Therapy CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 North America Cell Gene Therapy CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
11 North America Cell Gene Therapy CDMO Market - Competitive Landscape |
11.1 North America Cell Gene Therapy CDMO Market Revenue Share, By Companies, 2022 |
11.2 North America Cell Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here